The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Large pharma companies at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

16 large pharma companies are at Festival of Biologics USA 2027 — 30 presentations on the program. Most represented: Pfizer (5 on the program), AbbVie (4 on the program), Bristol Myers Squibb (4 on the program). 8 of them have their own page in this guide. As of Oct 15, 2026.

All 126 organizations at Festival of Biologics USA 2027 →

Showing 1–15 of 16 organizations

Organization	Festival of Biologics USA 2027 Attendance
Pfizer New York, NY
pfizer.com Large pharma Develops and markets medicines and vaccines in oncology, inflammation and immunology, rare diseases and internal medicine.	Talk Tue Apr 13 12:00 Protein Engineering: title to be announced Talk Tue Apr 13 13:50 Vector construction for protein expression Bioprocessing Talk Tue Apr 13 14:30 Polysaccharide drug substance production: Optimization and scale-up of purification unit operations Bioprocessing Talk Tue Apr 13 15:10 Process characterization and purification of proteins Bioprocessing Also Presenting at the meeting, beyond the sessions above
AbbVie North Chicago, IL
abbvie.com Large pharma Develops and markets medicines in immunology, oncology, neuroscience and eye care, plus aesthetics.	Talk Tue Apr 13 11:40 Predictive frameworks to improve drug discovery AI & Data Talk Tue Apr 13 13:50 Biophysical characterisation and analytics of novel proteins Manufacturing Talk Wed Apr 14 11:40 Using AI ML to make Biobetters AI & Data Talk Wed Apr 14 14:00 Protein generation to support exploratory immunology Protein Engineering
Bristol Myers Squibb Princeton, NJ
bms.com Large pharma Develops and markets medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience, including cell therapies.	Talk Tue Apr 13 15:10 Downstream operations for protein purification Protein Engineering Talk Tue Apr 13 17:20 A Roadmap for Actionable AI usage AI & Data Talk Wed Apr 14 13:20 Analytical development of novel antibodies CMC Talk Wed Apr 14 15:00 Engineering Next-Generation T-Cell Engagers for Solid Tumors How adding a second activating signal to antibodies that link T cells to tumor cells could strengthen and prolong attacks on solid tumors.
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Develops and markets medicines in oncology, cardiovascular, renal, respiratory, immunology and rare diseases.	Talk Wed Apr 14 13:20 Advances in antibody-radioconjugate technology Armed Antibodies Talk Wed Apr 14 14:20 Advances in high throughput screening technologies for antibody production Protein Engineering Talk Wed Apr 14 14:40 Unnatural Precision: Site-specific conjugation for next generation ADCs How choosing where and how drugs attach to antibodies yields stabler antibody–drug conjugates and ones that carry two different drugs.
Merck Rahway, NJ
merck.com Large pharma Develops and markets medicines and vaccines, including the cancer immunotherapy Keytruda; known as MSD outside the US and Canada.	Talk Tue Apr 13 12:00 Continuous downstream processing advances Bioprocessing Talk Wed Apr 14 14:40 De novo designs for recombinant antibodies Protein Engineering Also Presenting at the meeting, beyond the sessions above
Eli Lilly Indianapolis, IN
lilly.com Large pharma Develops and markets medicines for diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Apr 13 11:00 Antibody discovery against GPCRs & antibodies as tools for small molecule discovery. Antibodies for Immunotherapy Talk Wed Apr 14 14:40 From Propagation to Push-Button: Ready-to-Use Cells and Robotic Liquid Handling in Bioassay QC Lab How frozen ready-to-use cells and pipetting robots make the cell-based tests that check biologic drug batches more consistent and less manual.
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company in the Roche Group developing medicines for cancer, immunology, neuroscience and other serious diseases.	Talk Tue Apr 13 15:10 Exploring costimulatory receptors CD28 and 4-1BB for cancer immunotherapy Antibodies for Immunotherapy Talk Wed Apr 14 13:20 Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Protein Engineering
Gilead Sciences Foster City, CA
gilead.com Large pharma Develops and markets medicines for HIV, liver disease, inflammation and cancer, including cell therapies through Kite.	Talk Tue Apr 13 15:10 Engineering challenges in manufacturing ADCs Manufacturing Talk Wed Apr 14 11:20 Beginning with the End in Mind: Using the Target Product Profile to Guide Biologics Drug Product Development CMC
Amgen Thousand Oaks, CA
amgen.com Large pharma Develops and markets biologic medicines and biosimilars in inflammation, oncology, cardiovascular and rare diseases.	Talk Wed Apr 14 14:00 Stability support for early clinical programs CMC
Astellas Tokyo, Japan
astellas.com Large pharma Develops and markets medicines in oncology, urology, immunology and ophthalmology, and invests in cell and gene therapy.	Talk Tue Apr 13 11:00 Manufacturing Strategies for Cell Therapies
GSK London, United Kingdom
gsk.com Large pharma Develops and markets vaccines and specialty medicines in infectious diseases, HIV, respiratory, immunology and oncology.	Talk Tue Apr 13 13:25 Clinical Trials: title to be announced
Ipca Laboratories Mumbai, India
ipca.com Large pharma Makes and markets finished formulations and active pharmaceutical ingredients, and develops biosimilars.	Talk Tue Apr 13 14:30 Ensuring High Biosimilarity Through Advanced Processes and Characterization Approaches Biosimilars
Sanofi Paris, France
sanofi.com Large pharma Global pharmaceutical company with medicines and vaccines in immunology, rare diseases, neurology and oncology.	Talk Tue Apr 13 11:40 Formulation development for biologics Bioprocessing
Takeda Tokyo, Japan
takeda.com Large pharma Global pharmaceutical company with medicines in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.	Talk Wed Apr 14 11:20 Advancing AI for Drug Discovery AI & Data
Teva Tel Aviv, Israel
tevapharm.com Large pharma Pharmaceutical company and one of the largest makers of generic medicines, also selling specialty medicines and biosimilars.	Talk Wed Apr 14 11:40 Approaches to developing cell based bioassays CMC